Back to Results
First PageMeta Content
Merck / Rofecoxib / Sulfones / Merck & Co. / Tellabs /  Inc. v. Makor Issues & Rights /  Ltd. / Scienter / Pleading / Food and Drug Administration / Naproxen / Law / COX-2 inhibitors / Pharmacology


[removed]Merck & Co. v. Reynolds[removed])
Add to Reading List

Document Date: 2010-04-29 09:38:05


Open Document

File Size: 238,34 KB

Share Result on Facebook

Company

Makor Issues & Rights Ltd. / Bombardier / the New York Times / See Tellabs Inc. / Wall Street Journal / Merck Research Laboratories / MERCK & CO. INC. ET / Syllabus MERCK & CO. INC. ET / Tellabs / Detroit Timber & Lumber Co. / Dura Pharmaceuticals Inc. / COX / Bloomberg / /

Country

United States / /

Event

Legal Issues / Product Recall / Product Issues / /

Facility

SUPREME COURT OF THE / Women’s Hospital / Lynchburg College / SUPREME COURT OF THE UNITED STATES Syllabus MERCK / /

IndustryTerm

adverse car diovascular results / healthcare providers / /

Organization

Food and Drug Administration / District Court / Supreme Court / Women’s Hospital / FDA’s Arthritis Advisory Committee / U.S. Securities and Exchange Commission / SUPREME COURT OF THE UNITED STATES / Medicare / Congress / Court of Appeals / UN Court / SUPREME COURT OF THE UNITED STATES Syllabus MERCK / American Medical Association / FDA / Lynchburg College / /

Person

RICHARD REYNOLDS ET AL / REYNOLDS ET AL / /

Position

president / speaker / scientist / head of research / representative / Reporter / /

Product

naproxen / Vioxx / /

PublishedMedium

The Wall Street Journal / the Journal of the American Medical Association / the New York Times / /

SocialTag